Biosensors Market Segmentation:
Technology Segment Analysis
The electrochemical segment is predicted to account for a majority share of 73% in the global biosensors market by 2035. This leadership is attributable to its growing usage in point-of-care diagnosis as one of the most promising and emerging areas in identifying and measuring health indicators. This, as a result, magnifies the importance of electrochemical biosensors in developing systems for faster identification of analytes such as glucose, lactic acid, cholesterol, uric acid, blood ketones, hemoglobin, neurotransmitters, amino acids, soluble gases, and immunoglobulin. For instance, in October 2024, STMicroelectronics launched a new bio-sensing chip, ST1VAFE3BX, for healthcare wearables, including smartwatches, sports bands, connected rings, and smart glasses, backed by inertial sensing and AI core.
Application Segment Analysis
The medical segment in the biosensors market is set to garner a notable share throughout the assessed timeframe. This predominant captivity on revenue generation is driven by its utilization in a wide range of disease detection and management electronics. This can also be testified by the projected expansion of the smart diagnostic and monitoring medical device industry, exhibiting a remarkable CAGR till 2035. In addition, the heightened awareness about early diagnosis, personalized treatment, and accurate prognosis in cancer is contributing significantly to the segment’s proprietorship. Furthermore, the worldwide use of these devices in identifying pathogens such as viruses, bacteria, and parasites to facilitate timely intervention and infection control measures is fueling its augmentation.
Our in-depth analysis of the global biosensors market includes the following segments:
|
Application |
|
|
End-User |
|
|
Technology |
|
|
Product |
|
